ReviewFrontiers in pharmacology2026

AI-driven multi-omics biomarkers in precision breast cancer therapeutics: from discovery to clinical translation.

Dimitrios Stylianakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.